Prof Gavin Churchyard - The Aurum Institute

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans. NPJ vaccines

Seaton, K.E., Deal, A., Han, X., Li, S.S., Clayton, A., Heptinstall, J., Duerr, A., Allen, M.A., Shen, X., Sawant, S. and Yates, N.L., 2021. Meta-analysis of HIV-1 vaccine elicited mucosal antibodies ...
Resistance to Mycobacterium tuberculosis infection among household contacts: a multinational study.

Baliashvili, D., Gandhi, N.R., Kim, S., Hughes, M., Mave, V., Mendoza-Ticona, A., Gonzales, P., Kim, N., Selvamuthu, P., Badal-Faesen, S. and Upton, C., 2021. Resistance to Mycobacterium tuberculosis ...
Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial

Wallis, R.S., Ginindza, S., Beattie, T., Arjun, N., Sebe, M., Likoti, M., Edward, V.A., Rassool, M., Ahmed, K., Fielding, K. and Ahidjo, B.A., 2021. Adjunctive host-directed therapies for pulmonary tu...
Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial.

Demers, A.M., Kim, S., McCallum, S., Eisenach, K., Hughes, M., Naini, L., Mendoza-Ticona, A., Pradhan, N., Narunsky, K., Poongulali, S. and Badal-Faesen, S., 2021. Drug susceptibility patterns of Myco...
Cost-effectiveness of scaling up short course preventive therapy for tuberculosis among children across 12 countries.

Jo, Y., Gomes, I., Flack, J., Salazar-Austin, N., Churchyard, G., Chaisson, R.E. and Dowdy, D.W., 2021. Cost-effectiveness of scaling up short course preventive therapy for tuberculosis among childre...
Performance of GeneXpert MTB/RIF for diagnosing tuberculosis among symptomatic household contacts of index patients in South Africa.

Velen, K., Podewils, L.J., Shah, N.S., Lewis, J.J., Dinake, T., Churchyard, G.J., Reichler, M. and Charalambous, S., 2021, April. Performance of GeneXpert MTB/RIF for diagnosing tuberculosis among sym...
Pulmonary restriction predicts long-term pulmonary impairment in people with HIV and tuberculosis.

Auld, S.C., Kornfeld, H., Maenetje, P., Mlotshwa, M., Chase, W., Vangu, M.D.T., Torigian, D.A., Wallis, R.S., Churchyard, G. and Bisson, G.P., 2021. Pulmonary restriction predicts long-term pulmonary ...
Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial

Mpofu, R., Otwombe, K., Mlisana, K., Nchabeleng, M., Allen, M., Kublin, J., McElrath, M.J., Bekker, L.G., Churchyard, G., Gray, G. and Laher, F., 2021. Benign ethnic neutropenia in a South African pop...
TB Prevention in People With HIV: How Short Can We Go?

...
Call to action for an invigorated drive to scale up TB prevention

...
Concern as TB Preventative Treatment Declines

...
Q&A: Locally led leadership key to global health solutions

...
Locally-led development: We are willing and ready

We are willing and ready to lead, says Prof Gavin Churchyard in response to more funding being allocated to locally-led development organisations. Prof Churchyard, Aurum Group Chief Executive Officer...
Locally-Led: Operationalizing USAID’s New Vision

...
Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial

Wallis, R.S., Ginindza, S., Beattie, T., Arjun, N., Likoti, M., Sebe, M., Edward, V.A., Rassool, M., Ahmed, K., Fielding, K. and Ahidjo, B.A., 2022. Lung and blood early biomarkers for host-directed t...
The utility of repeat Xpert MTB/RIF testing to diagnose tuberculosis in HIV-positive adults with initial negative result.

Hanifa, Y., Fielding, K.L., Chihota, V.N., Adonis, L., Charalambous, S., Foster, N., Karstaedt, A., McCarthy, K., Nicol, M.P., Ndlovu, N.T. and Sinanovic, E., 2018. The utility of repeat Xpert MTB/RIF...
The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis risk.

Mulenga, H., Fiore-Gartland, A., Mendelsohn, S.C., Penn-Nicholson, A., Mbandi, S.K., Borate, B., Musvosvi, M., Tameris, M., Walzl, G., Naidoo, K. and Churchyard, G., 2022. The effect of host factors o...
In-depth: New guidelines and medicines poised to boost TB prevention efforts in SA

...
End-point definition and trial design to advance tuberculosis vaccine development.

Garcia-Basteiro, A.L., White, R.G., Tait, D., Schmidt, A.C., Rangaka, M.X., Quaife, M., Nemes, E., Mogg, R., Hill, P.C., Harris, R.C. and Hanekom, W.A., 2022. End-point definition and trial design to...
Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay Conversion.

Simmons, J.D., Dill-McFarland, K.A., Stein, C.M., Van, P.T., Chihota, V., Ntshiqa, T., Maenetje, P., Peterson, G.J., Benchek, P., Nsereko, M. and Velen, K., 2022. Monocyte Transcriptional Responses to...

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans. NPJ vaccines

Resistance to Mycobacterium tuberculosis infection among household contacts: a multinational study.

Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial

Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial.

Cost-effectiveness of scaling up short course preventive therapy for tuberculosis among children across 12 countries.

Performance of GeneXpert MTB/RIF for diagnosing tuberculosis among symptomatic household contacts of index patients in South Africa.

Pulmonary restriction predicts long-term pulmonary impairment in people with HIV and tuberculosis.

Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial

TB Prevention in People With HIV: How Short Can We Go?

Call to action for an invigorated drive to scale up TB prevention

Concern as TB Preventative Treatment Declines

Q&A: Locally led leadership key to global health solutions

Locally-led development: We are willing and ready

Locally-Led: Operationalizing USAID’s New Vision

Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial

The utility of repeat Xpert MTB/RIF testing to diagnose tuberculosis in HIV-positive adults with initial negative result.

The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis risk.

In-depth: New guidelines and medicines poised to boost TB prevention efforts in SA

End-point definition and trial design to advance tuberculosis vaccine development.

Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay Conversion.

Popular Tags

Most Read

Recent Posts